Humanities
Skip to main content Skip to main navigation menu Skip to site footer
  • Register
  • Login
  • Menu
  • Home
  • Current
  • Archives
  • Announcements
  • About
    • About the Journal
    • Submissions
    • Editorial Team
    • Privacy Statement
    • Contact
  • Register
  • Login

Journal of Education, Health and Sport

Adult Hypophosphatasia in Physically Active Individuals: Substrate Biochemistry (PLP, PPi, PEA), Stress-Fracture Phenotype, and Diagnostic Challenges
  • Home
  • /
  • Adult Hypophosphatasia in Physically Active Individuals: Substrate Biochemistry (PLP, PPi, PEA), Stress-Fracture Phenotype, and Diagnostic Challenges
  1. Home /
  2. Archives /
  3. Vol. 95 (2026) /
  4. Medical Sciences

Adult Hypophosphatasia in Physically Active Individuals: Substrate Biochemistry (PLP, PPi, PEA), Stress-Fracture Phenotype, and Diagnostic Challenges

Authors

  • Karolina Gardaś Medical University of Warsaw, ul. Żwirki i Wigury 61, 02-091 Warsaw, Poland https://orcid.org/0009-0006-0744-8192
  • Patryk Sielaff Medical University of Warsaw, ul. Żwirki i Wigury 61, 02-091 Warsaw, Poland https://orcid.org/0009-0005-8566-4715
  • Karolina Hernik Medical University of Warsaw, ul. Żwirki i Wigury 61, 02-091 Warsaw, Poland https://orcid.org/0009-0008-1097-8957
  • Artur Brudek Collegium Medicum, The Jan Kochanowski University, Kielce, 25-317, Poland https://orcid.org/0009-0001-3984-5196
  • Mateusz Sucharski Military Institute of Medicine, ul. Szaserów 128, 04-141 Warsaw, Poland https://orcid.org/0009-0008-6460-2269
  • Jan Pawłasek Medical University of Warsaw, ul. Żwirki i Wigury 61, 02-091 Warsaw, Poland https://orcid.org/0009-0005-9244-8586
  • Hubert Piwar Medical University of Warsaw https://orcid.org/0009-0009-4333-9518
  • Monika Lis Mazovian "Bródnowski" Hospital, Ludwika Kondratowicza 8, 03-242 Warsaw, Poland https://orcid.org/0000-0003-4021-919X
  • Ewa Kacynel Medical University of Warsaw, Żwirki i Wigury 61, 02-091 Warsaw, Poland https://orcid.org/0009-0002-8290-9818

DOI:

https://doi.org/10.12775/JEHS.2026.95.73819%20

Keywords

hypophosphatasia (HPP), alkaline phosphatase, stress fractures, athletes, pyridoxal phosphate, vitamin B6

Abstract

Background. Hypophosphatasia (HPP) is a rare inborn error of metabolism caused by loss-of-function ALPL variants that reduce tissue-nonspecific alkaline phosphatase activity, producing persistently low serum alkaline phosphatase (ALP) and accumulation of pyridoxal-5'-phosphate (PLP/vitamin B6). In adults, HPP may present with recurrent metatarsal and femoral stress fractures, chronic pain and reduced function, features that overlap with overtraining, Relative Energy Deficiency in Sport (REDs) and the Female Athlete Triad.

Aim. To synthesise the published literature on adult HPP in athletes and physically active individuals, focusing on recurrent stress fractures, diagnostic delay, low ALP as a red flag and PLP/vitamin B6 as substrate markers.

Brief description of the state of knowledge. Direct evidence is limited to a few case reports (runners, an archer, a woman with no specified sport) and one case-finding study; in each, low ALP was the entry-point and PLP usually elevated. A podiatry study found ALPL variants in 2 of 13 patients with metatarsal stress fracture and low ALP. Contextual cohorts confirm a high burden of fractures, pain and impaired performance independent of bone mineral density, and antiresorptive therapy is linked to atypical femoral fractures in unrecognised HPP.

Summary. Adult HPP should be considered in active individuals with recurrent or non-healing stress fractures and persistently low age- and sex-adjusted ALP. Adding ALP to the athlete bone-health work-up, with reflex PLP and ALPL testing when ALP is low, may shorten diagnostic delay and prevent inappropriate antiresorptive treatment. HPP and the Female Athlete Triad/REDs can coexist, and general adult-HPP or consensus literature should not be over-interpreted as direct evidence in athletes.

References

1. Shaker JL. Stress and insufficiency fractures. Clin Rev Bone Miner Metab. 2018;16(1):3-15.

2. Mountjoy M, Ackerman KE, Bailey DM, Burke LM, Constantini N, Hackney AC, et al. 2023 International Olympic Committee's (IOC) consensus statement on Relative Energy Deficiency in Sport (REDs). Br J Sports Med. 2023;57(17):1073-97.

3. De Souza MJ, Williams NI, Misra M, Nattiv A, Joy E, Barrack M, et al. 2025 update to the Female Athlete Triad Coalition consensus statement part 1: state of the science and introduction of a new adolescent model. Sports Med. 2026;56(2):327-73.

4. Williams NI, De Souza MJ, Misra M, Nattiv A, Joy E, Barrack M, et al. 2025 update to the Female Athlete Triad Coalition consensus statement part 2: clinical guidelines for screening, diagnosis, treatment, and return to play for adolescents and adults. Sports Med. 2026;56(2):375-427.

5. Mornet E. Hypophosphatasia. Best Pract Res Clin Rheumatol. 2008;22(1):113-27.

6. Schmidt T, Schmidt C, Amling M, Kramer J, Barvencik F. Prevalence of low alkaline phosphatase activity in laboratory assessment: is hypophosphatasia an underdiagnosed disease? Orphanet J Rare Dis. 2021;16(1):452.

7. Tornero C, Navarro-Compan V, Tenorio JA, Garcia-Carazo S, Buno A, Monjo I, et al. Can we identify individuals with an ALPL variant in adults with persistent hypophosphatasaemia? Orphanet J Rare Dis. 2020;15(1):51.

8. Millan JL, Whyte MP. Alkaline phosphatase and hypophosphatasia. Calcif Tissue Int. 2016;98(4):398-416.

9. Whyte MP, Mahuren JD, Vrabel LA, Coburn SP. Markedly increased circulating pyridoxal-5'-phosphate levels in hypophosphatasia: alkaline phosphatase acts in vitamin B6 metabolism. J Clin Invest. 1985;76(2):752-6.

10. Whyte MP. Hypophosphatasia: an overview for 2017. Bone. 2017;102:15-25.

11. Baujat G, Cormier-Daire V, Le Merrer M. Hypophosphatasia: the disease in adults. Clin Rev Bone Miner Metab. 2013;11(2):78-83.

12. Berkseth KE, Tebben PJ, Drake MT, Hefferan TE, Jewison DE, Wermers RA. Clinical spectrum of hypophosphatasia diagnosed in adults. Bone. 2013;54(1):21-7.

13. Briot K, Roux C. Adult hypophosphatasia. Curr Opin Rheumatol. 2016;28(4):448-51.

14. McKiernan FE, Berg RL, Fuehrer J. Clinical and radiographic findings in adults with persistent hypophosphatasemia. J Bone Miner Res. 2014;29(7):1651-60.

15. Vinan-Vega MN, Abate EG. Hypophosphatasia: clinical assessment and management in the adult patient-a narrative review. Endocr Pract. 2018;24(12):1086-92.

16. Fanous N, Barb D. Adult hypophosphatasia manifests in a marathon runner. BMJ Case Rep. 2020;13(9):e234764.

17. Fink DA, Pasculli RM, Wright A, Katz K, Agrawal N, Turner R, et al. Unexpected hurdle in the race: hypophosphatasia unmasked by the Female Athlete Triad. Curr Sports Med Rep. 2019;18(12):434-6.

18. Ryan Z, Granley A, Vidlock K. Genetic hypophosphatasia as a cause of recurrent stress fractures in a female runner. Curr Sports Med Rep. 2026;25(2):47-9.

19. Riancho JA. Diagnostic approach to patients with low serum alkaline phosphatase. Calcif Tissue Int. 2023;112(3):289-96.

20. Akiyama T, Kubota T, Murayama K, Fujiwara M, Ohata Y, Ozono K, et al. Vitamin B6 status in hypophosphatasia: association with clinical severity, diagnostic utility, and effects on vitamin B6 metabolism by supplementation and enzyme replacement therapy. J Inherit Metab Dis. 2025;48(3):e70036.

21. Alvarez S, Ocampo A, Caso PC, Del Real A, Puente N, Vega AI, et al. Vitamin B6 challenge as a tool for detecting ALPL mutations and diagnosing hypophosphatasia. Osteoporos Int. 2025;36(9):1743-7.

22. Whyte MP, Zhang F, Wenkert D, Mack KE, Bijanki VN, Ericson KL, et al. Hypophosphatasia: vitamin B6 status of affected children and adults. Bone. 2022;154:116204.

23. Kato H, Hidaka N, Koga M, Kinoshita Y, Makita N, Nangaku M, et al. Radiological evaluation of pseudofracture after the administration of asfotase alfa in an adult with benign prenatal hypophosphatasia: a case report. Bone Rep. 2022;16:101163.

24. Windels O, Simon A, Muschol N, Yorgan T, Barvencik F. Successful treatment using asfotase alfa for delayed healing of a metatarsal stress fracture in an adolescent girl with hypophosphatasia. Osteoporos Int. 2026. Advance online publication.

25. Yavuz U, Sokucu S, Demir B, Akpinar E, Lapcin O, Atici Y, et al. An unusual stress fracture in an archer with hypophosphatasia. Case Rep Orthop. 2013;2013:350236.

26. Christidis G, Martin T, Walter F, Lammert F, Krawczyk M. Hypophosphatasia: an underappreciated cause of atraumatic stress fractures. Am J Med. 2022;135(1):e18-e19.

27. Koehler K, Atway S, Pipes J, Ing S. Diagnosis of hypophosphatasia in adults presenting with metatarsal stress fracture: proof-of-concept for a case-finding strategy. JBMR Plus. 2021;5(6):e10495.

28. Kishnani PS, Rockman-Greenberg C, Rauch F, Bhatti MT, Moseley S, Denker AE, et al. Five-year efficacy and safety of asfotase alfa therapy for adults and adolescents with hypophosphatasia. Bone. 2019;121:149-62.

29. Seefried L, Genest F, Hofmann C, Brandi ML, Rush E. Diagnosis and treatment of hypophosphatasia. Calcif Tissue Int. 2025;116(1):46.

30. Seefried L, Genest F, Kornak U, Semler O, Barvencik F, Hofmann C. Treatments for hypophosphatasia. Osteologie. 2020;29(4):275-82.

31. Hogler W, Langman C, Gomes da Silva H, Fang S, Linglart A, Ozono K, et al. Diagnostic delay is common among patients with hypophosphatasia: initial findings from a longitudinal, prospective, global registry. BMC Musculoskelet Disord. 2019;20(1):80.

32. Tabegna FGA, Garton M, D'Amore S, Skingle L, Dillon S, Duer MJ, et al. Pathophysiology of femoral fractures in hypophosphatasia. Curr Osteoporos Rep. 2025;23(1):36.

33. Genest F, Seefried L. Subtrochanteric and diaphyseal femoral fractures in hypophosphatasia-not atypical at all. Osteoporos Int. 2018;29(8):1815-25.

34. Lefever E, Witters P, Gielen E, Vanclooster A, Meersseman W, Morava E, et al. Hypophosphatasia in adults: clinical spectrum and its association with genetics and metabolic substrates. J Clin Densitom. 2020;23(3):340-8.

35. Sutton RA, Mumm S, Coburn SP, Ericson KL, Whyte MP. "Atypical femoral fractures" during bisphosphonate exposure in adult hypophosphatasia. J Bone Miner Res. 2012;27(5):987-94.

36. Tsiantouli E, Biver E, Chevalley T, Petrovic R, Hannouche D, Ferrari S. Prevalence of low serum alkaline phosphatase and hypophosphatasia in adult patients with atypical femur fractures. Calcif Tissue Int. 2022;110(6):703-11.

37. Braunstein NA. Multiple fractures, pain, and severe disability in a patient with adult-onset hypophosphatasia. Bone Rep. 2016;4:1-4.

38. Khan AA, Josse R, Kannu P, Villeneuve J, Paul T, Van Uum S, et al. Hypophosphatasia: Canadian update on diagnosis and management. Osteoporos Int. 2019;30(9):1713-22.

39. Whyte MP. Hypophosphatasia-aetiology, nosology, pathogenesis, diagnosis and treatment. Nat Rev Endocrinol. 2016;12(4):233-46.

40. Hepp N, Frederiksen AL, Duno M, Jorgensen NR, Jensen JB. Biochemical and clinical manifestations in adults with hypophosphatasia: a national cross-sectional study. Osteoporos Int. 2022;33(12):2595-605.

41. Genest F, Claussen L, Rak D, Seefried L. Bone mineral density and fracture risk in adult patients with hypophosphatasia. Osteoporos Int. 2021;32(2):377-85.

42. Durrough C, Colazo JM, Simmons J, Hu JR, Hudson M, Black M, et al. Characterization of physical, functional, and cognitive performance in 15 adults with hypophosphatasia. Bone. 2021;142:115695.

43. Seefried L, Dahir K, Petryk A, Hogler W, Linglart A, Martos-Moreno GA, et al. Burden of illness in adults with hypophosphatasia: data from the Global Hypophosphatasia Patient Registry. J Bone Miner Res. 2020;35(11):2171-8.

44. Dahir KM, Kishnani PS, Martos-Moreno GA, Linglart A, Petryk A, Rockman-Greenberg C, et al. Impact of muscular symptoms and/or pain on disease characteristics, disability, and quality of life in adult patients with hypophosphatasia: a cross-sectional analysis from the Global HPP Registry. Front Endocrinol (Lausanne). 2023;14:1138599.

45. Calmarza P, Lapresta C, Martinez Garcia M, Ochoa J, Sienes Bailo P, Acha Perez J, et al. Musculoskeletal pain and muscular weakness as the main symptoms of adult hypophosphatasia in a Spanish cohort: clinical characterization and identification of a new ALPL gene variant. J Bone Miner Metab. 2023;41(5):654-65.

46. Rauf MA, Kotecha J, Moss K. Reducing diagnostic delay in hypophosphatasia: a case series of 14 patients presenting to general rheumatology. Osteoporos Int. 2023;34(9):1647-52.

47. Desborough R, Nicklin P, Gossiel F, Balasubramanian M, Walsh JS, Petryk A, et al. Clinical and biochemical characteristics of adults with hypophosphatasia attending a metabolic bone clinic. Bone. 2021;144:115795.

48. Maheshwari KK, Maheshwari M, Shehryar M, Kareem HK, Sachmechi I. A rare case presentation of hypophosphatasia: bone pain and mild fatigue in a 79-year-old male. Eur J Rheumatol. 2025;12(3):1-3.

49. Al-Saoudi E, Hepp N, Jensen JB. Bilateral healing of pseudofractures in hypophosphatasia with teriparatide: a case report. J Med Case Rep. 2026;20(1):235.

50. Sodi R, Hall D. A man with recurrent fractures and foot pain. Clin Chem. 2018;64(4):639-44.

51. Hoff P, Mann A, Steinmuller M, Aliluev A. Clinical presentation of adults with persistently low alkaline phosphatase activity: a retrospective multicentre, cross-sectional study in Germany. BMJ Open. 2025;15(7):e097235.

52. Guanabens N, Blanch J, Martinez-Diaz-Guerra G, Munoz Torres M. Identification of hypophosphatasia in a clinical setting: clinical manifestations and diagnostic recommendations in adult patients. Med Clin (Barc). 2018;150(2):75-9.

53. Mornet E, Taillandier A, Domingues C, Dufour A, Benaloun E, Lavaud N, et al. Hypophosphatasia: a genetic-based nosology and new insights in genotype-phenotype correlation. Eur J Hum Genet. 2021;29(2):289-99.

54. Jandl NM, Schmidt T, Rolvien T, Sturznickel J, Chrysostomou K, von Vopelius E, et al. Genotype-phenotype associations in 72 adults with suspected ALPL-associated hypophosphatasia. Calcif Tissue Int. 2021;108(3):288-301.

55. Khan AA, Brandi ML, Rush ET, Ali DS, Al-Alwani H, Almonaei K, et al. Hypophosphatasia diagnosis: current state of the art and proposed diagnostic criteria for children and adults. Osteoporos Int. 2024;35(3):431-8.

56. Brandi ML, Khan AA, Rush ET, Ali DS, Al-Alwani H, Almonaei K, et al. The challenge of hypophosphatasia diagnosis in adults: results from the HPP International Working Group Literature Surveillance. Osteoporos Int. 2024;35(3):439-49.

57. Rush E, Brandi ML, Khan A, Ali DS, Al-Alwani H, Almonaei K, et al. Proposed diagnostic criteria for the diagnosis of hypophosphatasia in children and adolescents: results from the HPP International Working Group. Osteoporos Int. 2024;35(1):1-10.

58. Montero-Lopez R, Farman MR, Hogler F, Saraff V, Hogler W. Challenges in hypophosphatasia: suspicion, diagnosis, genetics, management, and follow-up. Horm Res Paediatr. 2025;98(6):736-45.

59. Bianchi ML, Bishop NJ, Guanabens N, Hofmann C, Jakob F, Roux C, et al. Hypophosphatasia in adolescents and adults: overview of diagnosis and treatment. Osteoporos Int. 2020;31(8):1445-60.

60. Tournis S, Yavropoulou MP, Polyzos SA, Doulgeraki A. Hypophosphatasia. J Clin Med. 2021;10(23):5676.

61. Belkhouribchia J, Bravenboer B, Meuwissen M, Velkeniers B. Osteomalacia with low alkaline phosphatase: a not so rare condition with important consequences. BMJ Case Rep. 2016;2016:bcr2015212827.

62. Kuehn K, Hahn A, Seefried L. Mineral intake and clinical symptoms in adult patients with hypophosphatasia. J Clin Endocrinol Metab. 2020;105(8):e2982-e2992.

63. Kuehn K, Hahn A, Seefried L. Impact of restricted phosphorus, calcium-adjusted diet on musculoskeletal and mental health in hypophosphatasia. J Endocr Soc. 2023;8(1):bvad150.

64. Wiedemann P, Schmidt FN, Amling M, Yorgan TA, Barvencik F. Zinc and vitamin D deficiency and supplementation in hypophosphatasia patients: a retrospective study. Bone. 2023;175:116849.

65. Langeveld M, Hollak CEM. Bone health in patients with inborn errors of metabolism. Rev Endocr Metab Disord. 2018;19(1):81-92.

66. Bowden SA, Foster BL. Profile of asfotase alfa in the treatment of hypophosphatasia: design, development, and place in therapy. Drug Des Devel Ther. 2018;12:3147-61.

67. Dahir KM, Dunbar NS. Medical management of hypophosphatasia: review of data on asfotase alfa. Curr Osteoporos Rep. 2025;23(1):14.

68. Genest F, Rak D, Petryk A, Seefried L. Physical function and health-related quality of life in adults treated with asfotase alfa for pediatric-onset hypophosphatasia. JBMR Plus. 2020;4(9):e10395.

69. Hadzimuratovic B, Haschka J, Hackl M, Diendorfer AB, Mittelbach A, Feurstein J, et al. Longitudinal course of circulating miRNAs in a patient with hypophosphatasia and asfotase alfa treatment: a case report. JBMR Plus. 2024;8(10):ziae107.

Journal of Education, Health and Sport

Downloads

  • PDF

Published

2026-11-16

How to Cite

1.
GARDAŚ , Karolina, SIELAFF, Patryk, HERNIK, Karolina, BRUDEK, Artur, SUCHARSKI, Mateusz, PAWŁASEK, Jan, PIWAR, Hubert, LIS, Monika and KACYNEL, Ewa. Adult Hypophosphatasia in Physically Active Individuals: Substrate Biochemistry (PLP, PPi, PEA), Stress-Fracture Phenotype, and Diagnostic Challenges. Journal of Education, Health and Sport. Online. 16 November 2026. Vol. 95, p. 73819. [Accessed 17 November 2026]. DOI 10.12775/JEHS.2026.95.73819 .
  • ISO 690
  • ACM
  • ACS
  • APA
  • ABNT
  • Chicago
  • Harvard
  • IEEE
  • MLA
  • Turabian
  • Vancouver
Download Citation
  • Endnote/Zotero/Mendeley (RIS)
  • BibTeX

Issue

Vol. 95 (2026)

Section

Medical Sciences

License

Copyright (c) 2026 Karolina Gardaś , Patryk Sielaff, Karolina Hernik, Artur Brudek, Mateusz Sucharski, Jan Pawłasek, Hubert Piwar, Monika Lis, Ewa Kacynel

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.

The periodical offers access to content in the Open Access system under the Creative Commons Attribution-NonCommercial-ShareAlike 4.0

Stats

Number of views and downloads: 22
Number of citations: 0

Search

Search

Browse

  • Issue archive

User

User

Current Issue

  • Atom logo
  • RSS2 logo
  • RSS1 logo

Information

  • For Readers
  • For Authors
  • For Librarians

Newsletter

Subscribe Unsubscribe

Tags

Search using one of provided tags:

hypophosphatasia (HPP), alkaline phosphatase, stress fractures, athletes, pyridoxal phosphate, vitamin B6
Up

Akademicka Platforma Czasopism

Najlepsze czasopisma naukowe i akademickie w jednym miejscu

apcz.umk.pl

Partners

  • Akademia Ignatianum w Krakowie
  • Akademickie Towarzystwo Andragogiczne
  • Fundacja Copernicus na rzecz Rozwoju Badań Naukowych
  • Instytut Historii im. Tadeusza Manteuffla Polskiej Akademii Nauk
  • Instytut Kultur Śródziemnomorskich i Orientalnych PAN
  • Instytut Tomistyczny
  • Karmelitański Instytut Duchowości w Krakowie
  • Ministerstwo Kultury i Dziedzictwa Narodowego
  • Państwowa Akademia Nauk Stosowanych w Krośnie
  • Państwowa Akademia Nauk Stosowanych we Włocławku
  • Państwowa Wyższa Szkoła Zawodowa im. Stanisława Pigonia w Krośnie
  • Polska Fundacja Przemysłu Kosmicznego
  • Polskie Towarzystwo Ekonomiczne
  • Polskie Towarzystwo Ludoznawcze
  • Towarzystwo Miłośników Torunia
  • Towarzystwo Naukowe w Toruniu
  • Uniwersytet im. Adama Mickiewicza w Poznaniu
  • Uniwersytet Komisji Edukacji Narodowej w Krakowie
  • Uniwersytet Mikołaja Kopernika
  • Uniwersytet w Białymstoku
  • Uniwersytet Warszawski
  • Wojewódzka Biblioteka Publiczna - Książnica Kopernikańska
  • Wyższe Seminarium Duchowne w Pelplinie / Wydawnictwo Diecezjalne „Bernardinum" w Pelplinie

© 2021- Nicolaus Copernicus University Accessibility statement Shop